TNF and neoplasm: Downregulation of NK cell-inhibitory receptors (NK-IRs) or upregulation of NK cell-activating receptors (NK-ARs) can trigger the release of TNF-α and interferon (IFN)-γ from NK cells, which in turn exert antibody-dependent cell-mediated cytotoxic effects to kill tumor cells [49, 50].